| First Author | Torrente Y | Year | 2000 |
| Journal | Hum Mol Genet | Volume | 9 |
| Issue | 12 | Pages | 1843-52 |
| PubMed ID | 10915773 | Mgi Jnum | J:63753 |
| Mgi Id | MGI:1861541 | Doi | 10.1093/hmg/9.12.1843 |
| Citation | Torrente Y, et al. (2000) Transplacental injection of somite-derived cells in mdx mouse embryos for the correction of dystrophin deficiency. Hum Mol Genet 9(12):1843-52 |
| abstractText | Duchenne muscular dystrophy (DMD) is a lethal recessive disease caused by the absence of dystrophin in skeletal muscle, heart and other tissues. No cure is available at present for DMD. Here we describe a new strategy for the correction of dystrophin deficiency based on the transplantation of normal somite-derived cells into mdx mouse embryos. Somite-derived cells were isolated from E11.5 transgenic mouse embryos expressing the LacZ gene under the control of the muscle-specific desmin promoter and injected into the uterine circulation of pregnant mdx mice at gestational days E11.5-E17. Approximately 30% of the injected mdx embryos survived the procedure. Donor somite-derived cells were able to cross the placenta and migrate into host embryonic tissues. The pattern of donor cell distribution in host tissues depended on the gestational age of the transplanted embryos. Cells were found in hindlimb muscles, diaphragm, heart and ribs in E11.5 treated embryos and in the skull, ribs, vertebrae and lung of E15-E17 treated embryos. Normal dystrophin transcripts were detected in muscle and bone by RT-PCR. Histochemical analysis showed co-localization of LacZ and dystrophin expression in 5% of soleus and quadriceps muscle fibres and in 4% of heart myocytes of two of seven 8-week-old treated mdx mice. |
